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Accurate Diagnosis After Multidisciplinary Tumor Board: A Case Report of
Cholangiocarcinoma
Abstract
Multidisciplinary tumor boards (MDTBs) provide a venue for discussion of diagnosis, staging, and
treatment of patients with cancer. MDTBs have been shown to improve diagnostic accuracy and staging,
exemplified in this patient with a hepatic flexure mass on colonoscopy and initial pathology suggestive of
primary colonic adenocarcinoma with surface mucosal involvement. However, subsequent CT imaging
revealed a biliary malignancy invading the colon. Discussion at a MDTB facilitated radiology-pathology
correlation, with subsequent immunohistochemical stains compatible with a cholangiocarcinoma with
transmural colonic invasion. Prompt and accurate diagnosis after the MDTB enabled the oncology team
to offer the proper treatment approach.
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CASE REPORT

Accurate Diagnosis After Multidisciplinary Tumor
Board: A Case Report of Cholangiocarcinoma
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a
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Abstract
Multidisciplinary tumor boards (MDTBs) provide a venue for discussion of diagnosis, staging, and treatment of
patients with cancer. MDTBs have been shown to improve diagnostic accuracy and staging, exempliﬁed in this patient
with a hepatic ﬂexure mass on colonoscopy and initial pathology suggestive of primary colonic adenocarcinoma with
surface mucosal involvement. However, subsequent CT imaging revealed a biliary malignancy invading the colon.
Discussion at a MDTB facilitated radiology-pathology correlation, with subsequent immunohistochemical stains
compatible with a cholangiocarcinoma with transmural colonic invasion. Prompt and accurate diagnosis after the MDTB
enabled the oncology team to offer the proper treatment approach.
Keywords: Cholangiocarcinoma, CCA, Multidisciplinary tumor board, Adenocarcinoma

1. Introduction

A

multidisciplinary tumor board (MDTB) is a
meeting of patient care providers from
different specialties to discuss the diagnosis, staging, and treatment of patients with cancer. At our
institution, a weekly MDTB is attended by medical
oncology, surgical oncology, radiation oncology,
interventional radiology, diagnostic radiology,
pathology, and palliative care. MDTBs have been
shown to enhance the multidisciplinary management of oncology patients. One beneﬁt in particular
is improved diagnostic accuracy and more accurate
staging1. This case report exempliﬁes how discussion at an MDTB led to a change in diagnosis from a
colon adenocarcinoma to an adenocarcinoma of
biliary etiology.

anemia despite iron supplementation. A recent fecal
occult blood smear performed the month prior was
positive. Her most recent colonoscopy was 6 years
prior, where multiple colonic polyps were identiﬁed
as adenomatous polyps. Her review of systems is
positive for chills, fatigue, shortness of breath, and
back pain. Physical exam reveals a ﬁrmness and
palpable mass in her right upper quadrant.

2. Case Presentation
An 88-year-old female with a history of resected
sigmoid adenocarcinoma was referred to gastroenterology for colonoscopy due to iron deﬁciency

Fig. 1. Image during colonoscopy showing a large, nearly obstructing
mass at the hepatic ﬂexure of the colon.
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A complete blood count showed iron deﬁciency
anemia (declining MCV, ferritin 11 mcg/L) that did
not improve with iron supplementation. A general
chemistry panel was normal, including normal
liver function tests (total bilirubin 0.4 mg/dL, AST
18 U/L, ALT 14 U/L, alkaline phosphytase 87 IU/L).
A CEA level was mildly elevated to 12.2 ng/mL. The
tumor marker CA 19e9 was mildly elevated to 587
U/mL.
Colonoscopy revealed a large, nearly obstructing
mass at the hepatic ﬂexure (Fig. 1). The colonoscope
was unable to traverse this region and it was uncertain if this was a primary colonic mass or
compression from an extra-colonic mass. Biopsies
were taken from the distal edge of the presumed
mass.
The biopsy specimen was sent to pathology for
evaluation. Given the suspicion for colon cancer,
specimens were stained using an HNPCC screening
proﬁle, including MLH1, MSH2, MSH6, PMS2 and
microsatellite instability. The H&E stain is demonstrated in Fig. 2. Based on the patient's history of
prior colonic adenocarcinoma as well as surface
mucosal colonic tumor involvement, an initial
diagnosis of intramucosal primary colonic adenocarcinoma was made.
After the colonoscopy, a staging CT abdomen and
pelvis was ordered. Imaging revealed a large,
approximately 15 cm heterogeneous mass in the
region of the gallbladder with invasion of the
hepatic ﬂexure of the colon as well as suspected
invasion of the liver (Fig. 3aeb). Cholelithiasis was

present within the mass, suggestive of a biliary
primary malignancy. Due to the discrepancy between the gallbladder mass on CT imaging and the
suspected primary colonic malignancy on pathology, the oncologist referred the case to a multidisciplinary tumor board. The tumor board facilitated
discussion between radiology, pathology, and
oncology.
With the new information of a predominantly
extra-colonic mass with invasion of the hepatic
ﬂexure of the colon, pathologists then performed
immunohistochemical stains for CK7, CK20, and
Cdx-2. These demonstrated two distinct populations
of glandular cells. The benign colonic epithelium was
positive for CK20 and Cdx-2, but negative for CK7.
The malignant epithelium was positive for immunostaining with CK7 and Cdx-2 but negative for
CK20 (Fig. 4). This immunohistochemical proﬁle is
most compatible with a gastric or pancreaticobiliary
malignancy. In conjunction with radiology ﬁndings,
the ﬁnal diagnosis was invasive cholangiocarcinoma
involving the colon.
The patient was referred to oncology and ultimately diagnosed with stage IV metastatic cholangiocarcinoma with invasion and obstruction at the
hepatic ﬂexure of the colon. Oncology started the
patient on Gemzar. To address the colonic
obstruction, the patient wanted to undergo the least
invasive procedure possible and opted for colonic
stenting. The patient is currently receiving comfort
care measures.

3. Discussion

Fig. 2. H&E stain at 100 magniﬁcation. Benign colonic crypts are
round if cut in cross-section or test-tube shaped if cut longitudinally.
Malignant glands are more complex, demonstrate nuclear enlargement
(purple color), and have colonized the surface epithelium (mimicking a
primary colonic adenocarcinoma).
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This case provides an excellent example of the
importance of a multidisciplinary approach to patient care. Case discussion at a MDTB facilitated
radiologyepathology correlation, which then led to
more accurate diagnosis and staging. A review of
pancreatic cancer patients discussed at MDTB found
a change in diagnosis in 22% of cases and a consequent treatment change in 15%1. In breast cancer, a
single institution study reported a change in diagnosis in 45% of breast cancer patients after discussion in a MDTB2.
Cholangiocarcinoma (CCA) is a cancer arising
from the bile duct epithelium and is most often
characterized histologically as an adenocarcinoma.
CCA is the second most common primary hepatobiliary carcinoma, with hepatocellular carcinoma
being the most common. Incidence of CCA in the
United States is increasing, making it an important
differential to consider. The diagnosis of cholangiocarcinoma can present quite the challenge, as
there are numerous conditions that can mimic
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Fig. 3aeb. Contrast-enhanced CT coronal (a) and sagittal (b) images demonstrating a hypoenhancing mass invading the colon (yellow arrows). The
mass engulfs gallstones (red arrow), suggesting biliary etiology of the mass.

cholangiocarcinoma including primary sclerosing
cholangitis, recurrent pyogenic cholangitis, autoimmune pancreatitis, sarcoidosis, hepatocellular
carcinoma, metastasis, among others3.

Cholangiocarcinoma displays a wide spectrum of
imaging features. Most CCAs cause biliary ductal
obstruction, although this may be hard to detect in
peripheral intrahepatic CCA. Sonography can show

Fig. 4aeb. (a) Malignant cells from colonic biopsy are negative for CK20, with benign colonic epithelium demonstrating CK20 positivity and staining
brown. (b) Malignant cells are strongly positive for CK7 (brown areas). This proﬁle is compatible with a gastric or pancreaticobiliary primary.
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variable echogenicity of the mass. CT often shows
ill-deﬁned, hypoattenuating liver masses; contrastenhanced CT may show ﬁndings such as arterial
rim enhancement and characteristic persistent
enhancement of the tumor on delayed venous
phase. Late enhancement of the tumor can be seen
with the late-phase scans, correlating to the amount
of ﬁbrous stroma within the tumor. If the tumor is
necrotic or composed of mucin-containing cells, this
delayed enhancement may be absent4,5.
Histopathology is often needed for a deﬁnitive
diagnosis in cholangiocarcinoma. Approximately 95%
of cholangiocarcinomas are identiﬁed as adenocarcinoma. As seen in this case, adenocarcinomas of the
biliary tract are positive for CK7 and Cdx-2 and
negative for CK20, whereas those of colonic origin are
positive for CK20 and Cdx-2 and negative for CK7.
The coordination between radiology, pathology,
and primary care physicians is imperative for a
prompt and accurate diagnosis. Without the proper
history and physical, cholangiocarcinoma may go
undetected. Even with this, cases can often go undetected until they are quite advanced due to the
nature of the disease. Once patients are sent for
further testing, anatomical information and imaging
ﬁndings from radiology are essential for pathologists to select the proper stains and immunohistochemistry to accurately pinpoint the appropriate
diagnosis. Without the imaging ﬁndings, this case
was presumed to be colonic in origin. Likewise,
without the pathologic ﬁndings, proper treatment
cannot be selected by the oncology team.
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4. Conclusion
Cholangiocarcinoma presentation varies widely,
and a multidisciplinary approach is often necessary
for accurate and deﬁnitive diagnosis. Discussion of
cases at MDTBs facilitates incorporation of radiology, pathology, and clinical ﬁndings imperative
for a prompt and accurate diagnosis. An accurate
diagnosis enables the oncology team to select the
proper treatment approach.
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